Key result
Natural medicines and their monomeric components show potential in treating ischemic cardiomyopathy by modulating mitochondrial quality control and endoplasmic reticulum function to reduce vascular injury.
Why the study?
Inflammatory coronary vascular damage causes ischemia and hypoxia in ischemic cardiomyopathy, but remains an overlooked aspect of cardioprotection.
This review highlights the interplay between mitochondrial and endoplasmic reticulum dysfunction in ischemic cardiomyopathy and proposes traditional Chinese medicine as a potential therapeutic avenue targeting these pathways.
Answers are grounded in this paper and cite their sources.
Natural medicines should not yet alter ischemic cardiomyopathy care; leaves open need for clinical trials.
Ischemic cardiomyopathy (ICM) is a special type or end stage of coronary heart disease or other irreversible ischemic myocardial injury. Inflammatory damage to coronary vessels is a crucial factor in causing stenosis or occlusion of coronary arteries, resulting in myocardial ischemia and hypoxia, but it is also an aspect of cardioprotection that is often overlooked. This review discusses the mechanisms of vascular injury during ICM, in which inflammation and oxidative stress interact and trigger cell death as the cause of coronary microvascular injury. Imbalances in endoplasmic reticulum function and mitochondrial quality control are important potential drivers of inflammation and oxidative stress. In addition, many studies have confirmed the therapeutic effects of Chinese herbal medicines and their natural monomeric components on vascular injuries. Their mitochondrial quality control and endoplasmic reticulum protection mechanisms as well as their role in combating improvements in vascular endothelial function and attenuating vascular injury are also summarized, with a perspective to provide a reference for pathologic understanding, drug research, and clinical application of ICM-associated coronary microvascular injury.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) conducted a review in Ischemic cardiomyopathy (ICM). Natural medicines and Chinese herbal medicines was evaluated. Natural medicines and their monomeric components show potential in treating ischemic cardiomyopathy by modulating mitochondrial quality control and endoplasmic reticulum function to reduce vascular injury.
Synapse has enriched 10 related papers. Consider them for comparative context: